Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28366 | 170 | 44.0 | 95% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | UHRF1 | Author keyword | 85 | 86% | 25% | 43 |
| 2 | ICBP90 | Author keyword | 45 | 94% | 9% | 16 |
| 3 | UHRF2 | Author keyword | 21 | 90% | 5% | 9 |
| 4 | NP95 | Author keyword | 6 | 71% | 3% | 5 |
| 5 | NIRF | Author keyword | 3 | 35% | 4% | 7 |
| 6 | HUMAN LIFESCI | Address | 2 | 67% | 1% | 2 |
| 7 | TRANFECTED CELL ARRAY PLATFORM | Address | 1 | 100% | 1% | 2 |
| 8 | UMRS 392 | Address | 1 | 100% | 1% | 2 |
| 9 | CNRS UMR 7213 | Address | 1 | 27% | 2% | 3 |
| 10 | UMR S392 | Address | 1 | 33% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | UHRF1 | 85 | 86% | 25% | 43 | Search UHRF1 | Search UHRF1 |
| 2 | ICBP90 | 45 | 94% | 9% | 16 | Search ICBP90 | Search ICBP90 |
| 3 | UHRF2 | 21 | 90% | 5% | 9 | Search UHRF2 | Search UHRF2 |
| 4 | NP95 | 6 | 71% | 3% | 5 | Search NP95 | Search NP95 |
| 5 | NIRF | 3 | 35% | 4% | 7 | Search NIRF | Search NIRF |
| 6 | CHEMOTHERAPY DRUG RESISTANCE | 1 | 50% | 1% | 1 | Search CHEMOTHERAPY+DRUG+RESISTANCE | Search CHEMOTHERAPY+DRUG+RESISTANCE |
| 7 | CHROMATIN BOUND PCNA | 1 | 50% | 1% | 1 | Search CHROMATIN+BOUND+PCNA | Search CHROMATIN+BOUND+PCNA |
| 8 | HEPATIC OUTGROWTH | 1 | 50% | 1% | 1 | Search HEPATIC+OUTGROWTH | Search HEPATIC+OUTGROWTH |
| 9 | IP MS | 1 | 50% | 1% | 1 | Search IP+MS | Search IP+MS |
| 10 | JURKAT T | 1 | 50% | 1% | 1 | Search JURKAT+T | Search JURKAT+T |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ICBP90 | 93 | 91% | 23% | 39 |
| 2 | SRA DOMAIN | 46 | 55% | 34% | 58 |
| 3 | NP95 | 28 | 81% | 10% | 17 |
| 4 | HEMI METHYLATED DNA | 22 | 47% | 21% | 35 |
| 5 | NP95 GENE | 18 | 89% | 5% | 8 |
| 6 | II ALPHA EXPRESSION | 15 | 50% | 13% | 22 |
| 7 | PROTEIN NP95 | 14 | 100% | 4% | 7 |
| 8 | NIRF | 9 | 83% | 3% | 5 |
| 9 | CCAAT BINDING PROTEIN | 9 | 33% | 13% | 22 |
| 10 | UHRF1 | 5 | 30% | 8% | 13 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties | 2011 | 19 | 90 | 31% |
| Recruitment of Dnmt1: Roles of the SRA Protein Np95 (Uhrf1) and Other Factors | 2011 | 14 | 70 | 33% |
| NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape | 2012 | 8 | 112 | 28% |
| Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers | 2011 | 9 | 124 | 25% |
| Molecular coupling of DNA methylation and histone methylation | 2010 | 63 | 101 | 11% |
| The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future? | 2007 | 64 | 117 | 22% |
| Cellular epigenetic stability and cancer | 2012 | 15 | 83 | 10% |
| Epigenetics, Development, and Cancer: Zebrafish Make Their Ark | 2011 | 6 | 79 | 13% |
| Partners in crime: The role of tandem modules in gene transcription | 2015 | 0 | 95 | 11% |
| Transcription Factors and Epigenetic Modulation: Its Therapeutic Implication in Chronic Kidney Disease | 2015 | 0 | 31 | 6% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HUMAN LIFESCI | 2 | 67% | 1.2% | 2 |
| 2 | TRANFECTED CELL ARRAY PLATFORM | 1 | 100% | 1.2% | 2 |
| 3 | UMRS 392 | 1 | 100% | 1.2% | 2 |
| 4 | CNRS UMR 7213 | 1 | 27% | 1.8% | 3 |
| 5 | UMR S392 | 1 | 33% | 1.2% | 2 |
| 6 | BIOCHIM IMMUNOCHIM | 1 | 50% | 0.6% | 1 |
| 7 | BREAST CANC CANC HOSPCANC ONCOL | 1 | 50% | 0.6% | 1 |
| 8 | CNRS UMR7213 | 1 | 50% | 0.6% | 1 |
| 9 | COMMESSARIAT ENERGIE ATOM | 1 | 50% | 0.6% | 1 |
| 10 | MED CELL BIOL MED GENET | 1 | 50% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000242650 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |
| 2 | 0.0000195417 | 5 HYDROXYMETHYLCYTOSINE//5HMC//5 CARBOXYLCYTOSINE |
| 3 | 0.0000109633 | HISTONE DEMETHYLASE//HISTONE DEMETHYLATION//LSD1 |
| 4 | 0.0000072743 | MIR 1260B//NOUVEL HOP ESTAING//DIETARY COMPOUNDS |
| 5 | 0.0000067327 | DIFFERENTIAL GENE EXPRESSION DETECTION//CANCER OUTLIER PROFILE ANALYSIS//BREAST CANC DIAG TREATMENT HENAN |
| 6 | 0.0000060949 | MSAP//RNA DIRECTED DNA METHYLATION//RDDM |
| 7 | 0.0000051819 | ALPHA NAC//NASCENT POLYPEPTIDE ASSOCIATED COMPLEX//FIAT |
| 8 | 0.0000047153 | ING4//ING1//P33ING1 |
| 9 | 0.0000045116 | HP1//POSITION EFFECT VARIEGATION//HETEROCHROMATIN |
| 10 | 0.0000044935 | USP22//UCH L1//DEUBIQUITINATING ENZYME |